Fondazione Irccs Istituto Nazionale Dei Tumori, Milano
Clinical trials sponsored by Fondazione Irccs Istituto Nazionale Dei Tumori, Milano, explained in plain language.
-
Breast cancer breakthrough? trial tests skipping surgery for top responders
Disease control Recruiting nowThis study looks at whether women with certain aggressive breast cancers (HER2-positive or triple-negative) who have a complete response to chemotherapy can safely avoid surgery or radiation. About 152 women will be monitored closely instead of receiving these local treatments. T…
Phase: PHASE2 • Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Disease control
Last updated Apr 29, 2026 05:32 UTC
-
New hope for prostate cancer: adding local treatment to drug therapy
Disease control Recruiting nowThis study looks at men with a type of prostate cancer that has spread but still responds to hormone therapy. After 6 months of standard drug treatment, some men will also receive either radiation or surgery to the prostate, while others continue with drugs alone. The goal is to …
Phase: NA • Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Disease control
Last updated Apr 29, 2026 05:29 UTC
-
Immune clues may predict desmoid tumor behavior
Knowledge-focused Recruiting nowThis study looks at the immune system of people with desmoid tumors, a rare growth of connective tissue. Researchers will analyze blood and tumor samples from 200 participants who are either being watched without treatment or receiving therapy. The goal is to find biological mark…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Apr 29, 2026 05:31 UTC
-
Scientists investigate if mouth germs can boost radiation success in head and neck cancer
Knowledge-focused Recruiting nowThis study looks at how the natural bacteria in your mouth might influence the effectiveness of radiation therapy for head and neck cancer. Researchers will collect saliva samples from 100 patients before, during, and after treatment to analyze the bacteria and viruses present. T…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Apr 29, 2026 05:29 UTC